July 13, 2020
July 13, 2020
PHILADELPHIA – Integral Molecular has launched an expanded panel of SARS-CoV-2 Reporter Virus Particles (RVP), which includes spike protein variants such as D614G and spike protein […]
June 10, 2020
June 10, 2020
PHILADELPHIA – Integral Molecular, the leader in discovering and characterizing antibodies against membrane protein and viral targets, is applying its Membrane Proteome Array (MPA) technology for […]
April 30, 2020
April 30, 2020
PHILADELPHIA – Integral Molecular announces the launch of SARS-CoV-2 Reporter Virus Particles (RVPs) to test patients for the presence of neutralizing antibodies, determine the effectiveness of […]
April 21, 2020
April 21, 2020
PHILADELPHIA – The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Integral Molecular $1 million to enable the application of Integral Molecular’s technology platforms […]
March 9, 2020
March 9, 2020
PHILADELPHIA –Integral Molecular announces the mobilization of two of its key technology platforms to aid in the discovery of vaccines and therapeutics against the novel coronavirus […]
February 12, 2020
February 12, 2020
PHILADELPHIA –Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, announces the launch of ReadyMap services, an expansion of its […]
January 8, 2020
January 8, 2020
PHILADELPHIA – Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, announces lead monoclonal antibodies (MAbs) against P2X7, a structurally complex ion channel that […]
November 14, 2019
November 14, 2019
PHILADELPHIA – (PR NEWSWIRE) – The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Integral Molecular a contract (75N93019C00073) which will provide up to […]
October 18, 2019
October 18, 2019
PHILADELPHIA – (PR NEWSWIRE) – Integral Molecular, the industry leader in membrane protein solutions, has expanded its research facility to a second location to accommodate an […]
September 26, 2019
September 26, 2019
PHILADELPHIA ¬ Sept. 26, 2019 — Integral Molecular, Inc. has been selected by The Wistar Institute, a global leader in cancer, immunology and infectious disease research […]
August 8, 2019
August 8, 2019
Integral Molecular is announcing a new collaboration with the Perelman School of Medicine at the University of Pennsylvania (Penn). Integral Molecular and Penn will work together […]
July 2, 2019
July 2, 2019
PHILADELPHIA -(PR NEWSWIRE)- Integral Molecular, the industry leader in discovering antibodies against multipass membrane proteins, recently presented data at the American Diabetes Association’s Annual Meeting on […]
May 28, 2019
May 28, 2019
PHILADELPHIA -(PR Newswire)- Integral Molecular, the industry leader in discovering antibodies against multipass membrane proteins, today announced that it has successfully reached the first milestone in […]
April 16, 2019
April 16, 2019
PHILADELPHIA-(PR NEWSWIRE)-Integral Molecular, the industry leader in membrane protein solutions, today announced the expansion of its two proprietary antibody characterization platforms, Shotgun Mutagenesis Epitope Mapping and […]
March 26, 2019
March 26, 2019
PHILADELPHIA–Integral Molecular, the industry leader in discovering antibodies against multipass membrane proteins, will showcase updated data on its discovery of highly specific Claudin 6 MAbs at […]
January 7, 2019
January 7, 2019
PHILADELPHIA–(PR NEWSWIRE)–Integral Molecular, the industry leader in membrane protein solutions, today announced that it has entered into a collaboration to discover new therapeutic targets in immuno-oncology […]
January 3, 2019
January 3, 2019
PHILADELPHIA–(PR NEWSWIRE)–Integral Molecular, the industry leader in the discovery of monoclonal antibodies (MAbs) against multipass membrane proteins, and Ono Pharmaceutical Co., Ltd. today announced that they […]
December 4, 2018
December 4, 2018
PHILADELPHIA–(PR NEWSWIRE)–Integral Molecular, the industry leader in antibody discovery against multipass membrane proteins, was awarded $1.4M by the NIH to develop its lead antibodies against cannabinoid […]
November 1, 2018
November 1, 2018
PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, the industry leader in membrane protein technologies, was awarded a Small Business Innovation Research (SBIR) grant from the NIH to initiate a target […]
September 18, 2018
September 18, 2018
PHILADELPHIA – (BUSINESS WIRE) – Integral Molecular, the industry leader in the discovery of monoclonal antibodies (MAbs) against membrane proteins, and Merus N.V. (Nasdaq:MRUS), a clinical-stage […]